May 23, 2018
BMJ: United States’ FDA providing insufficient information on post-approval drug effectiveness.
BMJ: United States’ FDA providing insufficient information on post-approval drug effectiveness.
#QualityFraud NYT: Opioids Making A Fortune For Pharma And Prescribers
There’ll be no more heroes They’ll be reduced to zero When that rough god goes riding Riding on in Van Morrison I got an email the other day that started with the greeting “Motherfucker!”. It wasn’t meant to be a friendly slap on the back – it was more of a threat. And it came […]
The Seventh Circuit: Data Breach Class Action Heaven?
From the ABA Journal reporting on a Philly Xarelto verdict that got overturned: Erdos rejected an alternate ground for overturning the verdict that was based on an Instagram photo by a lawyer for the plaintiff that used the hashtag #killinnazis. Erdos nonetheless scolded and punished the lawyer for the post, the Legal Intelligencer (sub. req.) […]
Toxic Chemical Harm In Dunbar Community